英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
AR-231453
|
733750-99-7 |
AR 231453
|
AR 231453;(2-FLUORO-4-METHANESULFONYL-PHENYL)-(6-[4-(3-ISOPROPYL-[1,2,4]OXADIAZOL-5-YL)-PIPERIDIN-1-YL]-5-NITRO-PYRIMIDIN-4-YL)-AMINE;N-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5-ni;N-(2-Fluoro-4-(methylsulfonyl)phenyl)-6-(4-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl)-5
|
C21H24FN7O5S |
505.5225632 | |
SB-674042
|
483313-22-0 |
(S)-1-[5-[2-氟苯基]-2-甲基噻唑-4-基]-1-[2-[[5-苯基-[1,3,4]恶二唑-2-基]甲基]吡咯烷-1-基]甲酮
|
(S)-1-[5-[2-氟苯基]-2-甲基噻唑-4-基]-1-[2-[[5-苯基-[1,3,4]恶二唑-2-基]甲基]吡咯烷-1-基]甲酮;[5-(2-FLUOROPHENYL)-2-METHYL-1,3-THIAZOL-4-YL]-[(2S)-2-[(5-PHENYL-1,4-OXADIAZOL-2-YL)METHYL]PYRROLIDIN-1-YL]METHANONE;SB 674042;SB674042
|
C24H21FN4O2S |
448.512543 | |
APD668
|
832714-46-2 |
ISOPROPYL 4-(1-(2-FLUORO-4-(METHYLSULFONYL)PHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLOXY)PIPERIDINE-1-CARBOXYLATE
|
异丙基 4-(1-(2-氟-4-(甲基磺酰基)苯基)-1H-吡唑并[3,4-D]嘧啶-4-基氧基)哌啶-1-羧酸
|
C21H24FN5O5S |
477.509163 | |
ER 172594-00
|
751475-53-3 |
2-(5,6-二乙氧基-7-氟-1,3-二氢-1-亚氨基-2H-异吲哚-2-基)-1-[3-叔丁基-4-甲氧基-5-(4-吗啉基)苯基]乙酮
|
2-(5,6-二乙氧基-7-氟-1,3-二氢-1-亚氨基-2H-异吲哚-2-基)-1-[3-叔丁基-4-甲氧基-5-(4-吗啉基)苯基]乙酮;阿托帕沙;2-(5,3-二氢-1-亚氨基-2H-异吲哚-2-基)-1-[3-(1,1-二甲基乙基)-4-甲氧基-5-(4-吗啉)苯基]乙酮
|
C29H38FN3O5 |
527.627523 | |
BAN ORL 24
|
475150-69-7 |
(2R)-1-苄基-N-(3-螺[异苯并呋喃-1(3H),4'-哌啶]-1'-丙基)-2-吡咯烷甲酰胺
|
(2R)-1-苄基-N-(3-螺[异苯并呋喃-1(3H),4'-哌啶]-1'-丙基)-2-吡咯烷甲酰胺
|
C27H35N3O2.2HCl |
||
2-[[2-Ethoxy-4-(4-hydroxy-1-piperidinyl(phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one
|
1234480-50-2 |
2-[[2-乙氧基-4-(4-羟基-1-哌啶基)苯基]氨基]-5,11-二氢-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮
|
2-[[2-乙氧基-4-(4-羟基-1-哌啶基)苯基]氨基]-5,11-二氢-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮;CS-641
|
C26H30N6O3 |
475 | |
Immethridine hydrobromide
|
87976-03-2 |
4-(1H-咪唑-5-甲基)吡啶
|
IMMETHRIDINE HYDROCHLORIDE;Immethridine;4-(1H-Imidazol-4-ylmethyl)pyridine dihydrobromide;4-(1H-Imidazol-5-ylmethyl)pyridine;dihydrobromide;Pyridine,4-(1H-imidazol-4-ylmethyl)-
|
C9H9N3.BrH |
240.103 | |
TAK-700 (Orteronel)
|
566939-85-3 |
6-[(7S)-7-羟基-6,7-二氢-5H-吡咯并[1,2-C]咪唑-7-基]-N-甲基-2-萘甲酰胺
|
CYP17A1 Inhibitor II, TAK-700 - CAS 566939-85-3 - Calbiochem;6-[(7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide;Orteronel;TAK-700 (S-form);TAK-700 (Orteronel);Orteronel, >=98%;(S)-Orteronel
|
C18H17N3O2 |
307.34648 | |
LY2811376
|
1194044-20-6 |
(4S)-4-[2,4-二氟-5-(5-嘧啶基)苯基]-5,6-二氢-4-甲基-4H-1,3-噻嗪-2-胺
|
(4S)-4-[2,4-二氟-5-(5-嘧啶基)苯基]-5,6-二氢-4-甲基-4H-1,3-噻嗪-2-胺;(4S)-4-[2,4-二氟-5-(5-嘧啶)苯基]-5,3-噻嗪-2-胺;CS-1893;LY 2811376;LY-2811376
|
C15H14F2N4S |
320.3602664 | |
GW791343 Hydrochloride
|
309712-55-8 |
GW791343 HCl
|
GW 791343 TRIHYDROCHLORIDE;GW-791343 TRIHYDROCHLORIDE;
|
C20H27Cl3F2N4O |
483.810386 | |
PF-03814735
|
942487-16-3 |
N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氢萘-1,4-亚氨-9-基]-2-氧代乙基]乙酰胺
|
N-[2-[(1S,4R)-6-[[4-(环丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氢萘-1,4-亚氨-9-基]-2-氧代乙基]乙酰胺;CS-240
|
C23H25F3N6O2 |
474.4788096 | -0 |
PF 543
|
1415562-82-1 |
(2R)-1-[[4-[[3-甲基-5-[(苯磺酰基)甲基]苯氧基]甲基]苯基]甲基]-2-吡咯烷甲醇
|
(2R)-1-[[4-[[3-甲基-5-[(苯磺酰基)甲基]苯氧基]甲基]苯基]甲基]-2-吡咯烷甲醇
|
C27H31NO4S |
465.60434 | |
Sb-742457
|
607742-69-8 |
3-苯基磺酰基-8-(哌嗪-1-基)喹啉
|
3-苯基磺酰基-8-(哌嗪-1-基)喹啉;3-苯磺酰基-8-(哌嗪-1-基)喹啉;CS-579;SB 742457;RVT 101;SB742457;RVT101;CS-2723
|
C19H19N3O2S |
353.444 | |
PF 04447943
|
1082744-20-4 |
PF 4447943
|
PF04447943;PF 04447943;PF 4447943;PF 4447943;PF-4447943
|
C20H25N7O2 |
395.4582 | |
EHop-016
|
1380432-32-5 |
EHOP-016;N4-(9-ETHYL-9H-CARBAZOL-3-YL)-N2-(3-MORPHOLIN-4-YL-PROPYL)-PYRIMIDINE-2,4-DIAMINE
|
EHOP-016;N4-(9-ETHYL-9H-CARBAZOL-3-YL)-N2-(3-MORPHOLIN-4-YL-PROPYL)-PYRIMIDINE-2,4-DIAMINE;N4-(9-乙基-9H-咔唑-3-基)-N2-[3-(4-吗啉基)丙基]-2,4-嘧啶二胺;EHOP 016;EHOP016
|
C25H30N6O |
430.5453 | -0 |
SNC 80
|
156727-74-1 |
(+)-4-[(ΑR)-Α-((2S,5R)-4-烯丙基-2,5-二甲基-1-哌嗪基)-3-甲氧基苄基]-N,N-二乙基苯酰胺
|
(+)-4-[(ΑR)-Α-((2S,5R)-4-烯丙基-2,5-二甲基-1-哌嗪基)-3-甲氧基苄基]-N,N-二乙基苯酰胺;4-[(R)-[(2S,5R)-2,5-二甲基-4-(2-丙烯-1-基)-1-哌嗪基](3-甲氧基苯基)甲基]-N,N-二乙基苯甲酰胺
|
C28H39N3O2 |
449.63 | |
MBX2982
|
1037792-44-1 |
5-乙基-2-[4-[4-[[[4-(1H-四氮唑-1-基)苯基]氧基]甲基]噻唑-2-基]哌啶-1-基]嘧啶
|
MBX2982;5-Ethyl-2-[4-[4-[[[4-(1H-tetrazol-1-yl)phenyl]oxy]methyl]thiazol-2-yl]piperidin-1-yl]pyrimidine;MBX2982 / MBX-2982;5-Ethyl-2-[4-[4-[[[4-(1H-tetrazol-1-yl)phenyl]oxy]methyl]thiazol-2-yl]piperidin-1-yl]pyrimidine MBX-2982;pyrimidine, 5-ethyl-2-[4-[4-[[4-(1h-tetrazol-1-yl)phenoxy]methyl]-2-thiazolyl]-1-piperidinyl]-;2-[1-(5-ethylpyrimidin-2-yl)-4-piperidyl]-4-[[4-(tetrazol-1-yl)phenoxy]methyl]thiazole;MBX-2982, >=98%;SAR-260093
|
C22H24N8OS |
448.54396 | |
(Z)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboxamidine
|
1204669-58-8 |
艾卡哚司他
|
INCB024360;INCB-024360;INCB 024360;INCB-24360(INCB-024360);[C(Z)]-4-[[2-[(氨基磺酰基)氨基]乙基]氨基]-N-(3-溴-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒;艾卡哚司他
|
C11H13BrFN7O4S |
438.2328232 | |
Mps1-IN-2
|
1228817-38-6 |
9-环戊基-2-[[2-乙氧基-4-(4-羟基哌啶-1-基)苯基]氨基]-5-甲基-8,9-二氢-5H-嘧啶并[4,5-B][1,4]二氮杂卓-6(7H)-酮
|
9-Cyclopentyl-2-[[2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino]-5-methyl-8,9-dihydro-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one Mps1-in-2;Mps1-IN-2;Msp1-IN-2;9-Cyclopentyl-2-[[2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino]-5-methyl-8,9-dihydro-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one
|
|||
Nutlin-3b
|
675576-97-3 |
4-[[(4R,5S)-4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮
|
4-[[(4R,5S)-4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮;NUTLIN-3B;NUTLIN 3B;(+)-NUTLIN-3;NUTLIN 3B
|
C30H30Cl2N4O4 |
581.4896 |